Validation of the ELN2024 and Mayo Genetic Risk Models in an External Cohort of 352 Patients With Newly Diagnosed AML
Marco Roncador1, Maddalena Marconato1, Jeremy Werner Deuel1
1Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
American Journal of Hematology
|July 15, 2025
Abstract
No abstract available in PubMed .


